These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27538610)

  • 41. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
    Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W
    Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Putaminal hyperintensity on T1-weighted MR imaging in patients with the Parkinson variant of multiple system atrophy.
    Ito S; Shirai W; Hattori T
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):689-92. PubMed ID: 19147717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
    Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
    Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.
    Wang N; Yang H; Li C; Fan G; Luo X
    Eur Radiol; 2017 Aug; 27(8):3174-3180. PubMed ID: 28105503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "One line": A method for differential diagnosis of parkinsonian syndromes.
    Sako W; Abe T; Haji S; Murakami N; Osaki Y; Izumi Y; Harada M; Kaji R
    Acta Neurol Scand; 2019 Sep; 140(3):229-235. PubMed ID: 31225648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Song IU; Yoo I; Chung YA; Jeong J
    Nucl Med Commun; 2015 Oct; 36(10):1049-54. PubMed ID: 26087241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The clinical application value of brain
    Gu Q; Chen SF; Chen KL; Huang YY; Ge JJ; Zuo CT; Cui M; Dong Q; Yu JT
    Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3294-3300. PubMed ID: 37926574
    [No Abstract]   [Full Text] [Related]  

  • 49. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
    Matsui H; Udaka F; Oda M; Tamura A; Kubori T; Nishinaka K; Kameyama M
    Ann Nucl Med; 2005 May; 19(3):225-9. PubMed ID: 15981676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in the intra-cerebellar connections and graph theoretical measures between Parkinson's disease and multiple system atrophy.
    Sako W; Abe T; Furukawa T; Oki R; Haji S; Murakami N; Izumi Y; Harada M; Kaji R
    J Neurol Sci; 2019 May; 400():129-134. PubMed ID: 30928779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
    Seppi K; Schocke MF; Donnemiller E; Esterhammer R; Kremser C; Scherfler C; Diem A; Jaschke W; Wenning GK; Poewe W
    Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Criteria-unfulfilled multiple system atrophy at an initial stage exhibits laterality of middle cerebellar peduncles.
    Furuta M; Sato M; Tsukagoshi S; Tsushima Y; Ikeda Y
    J Neurol Sci; 2022 Jul; 438():120281. PubMed ID: 35609364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy.
    Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M
    Auton Neurosci; 2005 Apr; 119(1):56-60. PubMed ID: 15893708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The difference in putamen volume between MSA and PD: evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    Parkinsonism Relat Disord; 2014 Aug; 20(8):873-7. PubMed ID: 24844749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gray Matter Atrophy in Parkinson's Disease and the Parkinsonian Variant of Multiple System Atrophy: A Combined ROI- and Voxel-Based Morphometric Study.
    Cui X; Li L; Yu L; Xing H; Chang H; Zhao L; Qian J; Song Q; Zhou S; Dong C
    Clinics (Sao Paulo); 2020; 75():e1505. PubMed ID: 32555945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging.
    Marini C; Bandettini di Poggio M; Pomposelli E; Marchese R; Nobili F; Morbelli SD; Villa G; Abbruzzese G; Sambuceti G
    Clin Nucl Med; 2010 May; 35(5):311-6. PubMed ID: 20395701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differentiation between Parkinson's Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle.
    Wang J; Sugiyama A; Yokota H; Hirano S; Yamamoto T; Yamanaka Y; Araki N; Ito S; Paul F; Kuwabara S
    Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential value of brain magnetic resonance imaging in multiple system atrophy cerebellar phenotype and spinocerebellar ataxias.
    Kim M; Ahn JH; Cho Y; Kim JS; Youn J; Cho JW
    Sci Rep; 2019 Nov; 9(1):17329. PubMed ID: 31758059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.